NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

CLEAR SYNERGY Neutrophil Substudy

Active, not recruiting

Conditions: STEMI - ST Elevation Myocardial Infarction
Neutrophils.Hypersegmented &#X7C; Bld-Ser-Plas

Interventions: Drug: Colchicine Pill

First Posted Date: 2019-03-14

Last Posted Date: 2024-01-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 322

Registration Number: NCT03874338

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

ED-Home Pilot Study

Not Applicable

Completed

Conditions: Housing Problems
Drug Use
Alcohol; Use, Problem

Interventions: Behavioral: Referral to homelessness prevention services
Behavioral: Substance use services
Behavioral: Follow-up

First Posted Date: 2019-03-06

Last Posted Date: 2022-08-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT03864341

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Fenfluramine in CDKL5 Deficiency Disorder (CDD)

Phase 2

Completed

Conditions: CDD

Interventions: Drug: Fenfluramine Hydrochloride

First Posted Date: 2019-03-04

Last Posted Date: 2023-10-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 7

Registration Number: NCT03861871

Locations: 🇺🇸
New York Langone Health Comprehensive Epilespy Center, New York, New York, United States

Polyp Measurement Device

Not Applicable

Terminated

Conditions: Colorectal Cancer

Interventions: Device: Micro-Tech Endoscopic Gauge

First Posted Date: 2019-02-27

Last Posted Date: 2021-06-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 36

Registration Number: NCT03856255

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

Phase 1

Terminated

Conditions: Prostate Cancer

Interventions: Drug: DKN-01
Drug: Docetaxel

First Posted Date: 2019-02-12

Last Posted Date: 2023-12-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 18

Registration Number: NCT03837353

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 2 locations

Equine Facilitated CBT Group Therapy for Youth Anxiety

Not Applicable

Terminated

Conditions: Anxiety

Interventions: Other: WLC
Behavioral: TAU is equine-facilitated group therapy
Behavioral: Augmented equine-facilitated CBT group program

First Posted Date: 2019-02-12

Last Posted Date: 2020-09-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 59

Registration Number: NCT03838835

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

tDCS for the Management of Multiple Sclerosis Related Fatigue

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Device: Active tDCS
Device: sham tDCS

First Posted Date: 2019-02-12

Last Posted Date: 2021-12-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 122

Registration Number: NCT03838770

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Evaluating the Use of Tranexamic Acid (TXA) in Total Joint Arthroplasty

Phase 4

Terminated

Conditions: Blood Loss

Interventions: Drug: Intravenous Placebo
Drug: Intravenous Tranexamic Acid

First Posted Date: 2019-02-01

Last Posted Date: 2021-09-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 52

Registration Number: NCT03825939

Locations: 🇺🇸
Winthrop University Hospital, Mineola, New York, United States

Hippocampal Memory Circuits in Delusions

Completed

Conditions: Psychosis

Interventions: Diagnostic Test: Pattern Separation Paradigm
Diagnostic Test: Sequential Associative Mismatch Paradigm
Diagnostic Test: Encoding Plasticity Paradigm

First Posted Date: 2019-01-30

Last Posted Date: 2024-04-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 212

Registration Number: NCT03822910

Locations: 🇺🇸
New York Langone Health, New York, New York, United States
🇨🇳
Shanghai Mental Health Center, Shanghai, China
🇨🇳
Suzhou Guangji Hospital, Suzhou, China

Anti-stigma Intervention for Chinese American Older Adults

Not Applicable

Completed

Conditions: Anxiety Disorders
Mood Disorders

Interventions: Behavioral: 10 sessions of ASGI

First Posted Date: 2019-01-29

Last Posted Date: 2020-05-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 16

Registration Number: NCT03820297

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy